US Antimony Corp Files 8-K: Director/Officer Changes & Financials

TL;DR

UAMY filed an 8-K on 11/24/25 covering leadership changes and financials.

AI Summary

United States Antimony Corporation filed an 8-K on November 24, 2025, reporting changes in directors and officers, a Regulation FD disclosure, and financial statements. The filing also includes exhibits related to these events. The company is incorporated in Texas and its fiscal year ends on December 31.

Why It Matters

This filing provides crucial updates on the company's leadership and financial reporting, which can impact investor confidence and strategic direction.

Risk Assessment

Risk Level: low — The filing is a routine 8-K reporting standard corporate events and financial disclosures, not indicating immediate operational or financial distress.

Key Players & Entities

• UNITED STATES ANTIMONY CORP (company) — Registrant
• November 24, 2025 (date) — Date of earliest event reported
• Texas (location) — State of incorporation

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock, $0.01 par value UAMY NYSE American Comm
• $285 billion — Mr. Marinelli has advised on more than $285 billion in M&A, public and private equity, and

Filing Documents

• tm2532165d1_8k.htm (8-K) — 31KB
• tm2532165d1_ex99-1.htm (EX-99.1) — 13KB
• tm2532165d1_ex99-1img001.jpg (GRAPHIC) — 7KB
• 0001104659-25-115724.txt ( ) — 263KB
• uamy-20251124.xsd (EX-101.SCH) — 4KB
• uamy-20251124_def.xml (EX-101.DEF) — 26KB
• uamy-20251124_lab.xml (EX-101.LAB) — 36KB
• uamy-20251124_pre.xml (EX-101.PRE) — 25KB
• tm2532165d1_8k_htm.xml (XML) — 5KB

02 – Departure of Directors or Certain Officers; Election

Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On November 24, 2025, upon the recommendation of the Governance and Nominating Committee, the Board of Directors (the "Board") of United States Antimony Corporation (NYSE: UAMY) (NYSE Texas: UAMY) ("USAC," "US Antimony," or the "Company") appointed Jon R. Marinelli, to serve as a director of the Company, effective immediately. With Mr. Marinelli's appointment, the USAC board size increases to seven members, five of which are Independent. Mr. Marinelli has also been appointed Chairman of a new board committee formed yesterday, the Finance Committee. Mr. Marinelli is a seasoned financial executive and investment professional with more than 25 years of experience in capital markets, M&A, and strategic advisory roles, and has an early-career background in technology. He is the Founder and Principal of 1042 Capital Partners, where he manages public and private investments. Previously, he served as Group Head and Managing Director of U.S. Energy at BMO Capital Markets, and before that held senior roles in Deutsche Bank's Global Banking–Natural Resources Group, the successor to Bankers Trust. Over his career, Mr. Marinelli has advised on more than $285 billion in M&A, public and private equity, and debt transactions. He holds an MBA from Rice University and a BS from Miami University. Mr. Marinelli will serve until the Company's next annual meeting of shareholders and until his successor is duly elected and qualified, or until his earlier death, resignation, or removal. There are no arrangements or understandings between Mr. Marinelli and any other person pursuant to which he was selected as a director, and there are no transactions involving Mr. Marinelli that are required to be disclosed under Item 404(a) of Regulation S-K. Any compensation payable to Mr. Marinelli for his service as a director will be consist

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On November 25, 2025, US Antimony issued a press release ("Press Release") announcing the appointment of Jon R. Marinelli to the Board. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such filing. This Item 7.01 of this Current Report on Form 8-K will not be deemed an admission as the materiality of any information in this Item 7.01 that is required to be disclosed solely by Regulation FD.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release issued by United States Antimony Corporation dated November 25, 2025 104 Cover Page Interactive Data File (embedded with the inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. UNITED STATES ANTIMONY CORPORATION Dated: November 25, 2025 By: /s/ Richard R. Isaak Richard R. Isaak SVP, Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR